| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| RIKER LAUREN | Senior Vice President, Finance | C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE | /s/ Kristen Williams, Attorney-in-Fact | 05 Jun 2025 | 0001545439 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCRX | Common Stock | Tax liability | $89,074 | -3,374 | -4.9% | $26.40 | 65,142 | 03 Jun 2025 | Direct | F1 |
| transaction | PCRX | Common Stock | Sale | $146,208 | -5,578 | -8.6% | $26.21 | 59,564 | 04 Jun 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.15 to $26.38, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2. |